116 related articles for article (PubMed ID: 16296155)
1. [Graft-versus-host-like flexural eruption after autologous stem cell transplantation].
Riemann H; Thomas M; Metze D
J Dtsch Dermatol Ges; 2003 Aug; 1(8):643-5. PubMed ID: 16296155
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
3. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
4. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
5. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
[TBL] [Abstract][Full Text] [Related]
6. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
[TBL] [Abstract][Full Text] [Related]
7. [Inv(16)-type acute myeloid leukemia with repeated skin infiltration without bone marrow relapse before and after allogeneic hematopoietic stem cell transplantation].
Tokita K; Takahashi W; Arai H; Handa T; Nakamura Y; Maki K; Sasaki K; Mitani K
Rinsho Ketsueki; 2013 Dec; 54(12):2203-6. PubMed ID: 24452154
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell transplantation for childhood myeloid malignancies after high-dose thiotepa, busulfan and cyclophosphamide.
Worth L; Tran H; Petropoulos D; Culbert S; Mullen C; Roberts W; Przepiorka D; Chan K
Bone Marrow Transplant; 1999 Nov; 24(9):947-52. PubMed ID: 10556952
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.
Alimoghaddam K; Ghavamzadeh A; Jahani M; Jalali A; Jorjani H; Iravani M; Hamidieh AA; Mousavi A; Bahar B; Behfar M; Derakhshandeh R; Rostami S
Arch Iran Med; 2011 Sep; 14(5):332-4. PubMed ID: 21888457
[TBL] [Abstract][Full Text] [Related]
11. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery.
Bauer DJ; Hood AF; Horn TD
Arch Dermatol; 1993 Jul; 129(7):855-8. PubMed ID: 8323305
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
14. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Novitzky N; Thomas V; du Toit C; McDonald A
Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
[TBL] [Abstract][Full Text] [Related]
16. The Cape Town experience with haematopoietic stem cell transplantation: the paediatric programme.
Roux P; Novitzky N
S Afr Med J; 2000 Aug; 90(8):804-11. PubMed ID: 11022631
[TBL] [Abstract][Full Text] [Related]
17. Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation.
Nakamura H; Nakao T; Ujiie H; Karasuno T; Teshima H; Komatsu K; Ishiguro S; Hiraoka A; Masaoka T
J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S457-61. PubMed ID: 10329849
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
19. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic stem cell transplantation: principles and practice].
Burdach S; Nürnberger W; Göbel U
Praxis (Bern 1994); 1996 Jun; 85(23):741-8. PubMed ID: 8693241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
